Frontlight ResearchEarly access
Taking people in GermanyPhase 1
PLX-PAD cell injections into the knee for mild to moderate osteoarthritis
Tests the safety of PLX-PAD cell injections in people with knee osteoarthritis.
Key facts
- Who runs it
- Charite Universitaetsmedizin Berlin KöR
- Where
- Berlin, GermanySee the site
- Trial code
- EU 2024-517421-12-00
- U1111-1317-3338
- Registry title
- A phase I, prospective, mono-center, double-blinded, randomized, controlled study to assess the safety and tolerability of intraarticular injection of PLX-PAD cells for the treatment of mild to moderate knee osteoarthritis – PROTO–I
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 18 people, planned
- Started
- 25 Aug 2026
- Planned end
- 15 Nov 2026
- Type of study
- Interventional
- Record updated
- 21 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with mild to moderate knee osteoarthritis. It tests the safety of PLX-PAD cells injected into the knee joint.
- Age
- 18 Years and older
- Sex
- All sexes can join
- Disease stage
- Mild to moderate knee osteoarthritis
Main reasons for not taking part
- Healthy volunteers cannot join
Where in Germany
- Charite Universitaetsmedizin Berlin KöRBerlin, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- PLX-PAD cell injections into the knee for mild to moderate osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 21 July 2026